Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Improvements to Biosurveillance and Detection Methods

by Global Biodefense Staff
August 26, 2016
Global Biosurveillance Networks

The U.S. Department of Homeland Security (DHS) is conducting market research to determine the availability of emerging technologies that can improve the detection and characterization of biological threat agent signatures.

Highlighted areas of interest include:

  • Improvement in the activity, stability and capabilities of amplification enzymes and polymerases used in the analysis of nucleic acids derived from select and non-select agents.
  • Development of novel primer and probe chemistries, methods to reduce or defeat primer-dimer formation, provide methods and reagents (fluor and quencher dyes) to increase the sensitivity and spectral range of detection.
  • Development of new and novel filter materials for the recovery of nucleic acid signatures and the use of (RNA and DNA) nuclease inhibitors in the filters to increase stability of signature nucleic acids, and subsequently the rates of recovery from environmental filters of various compositions.
  • Development of novel signature extraction chemistries to allow for the recovery and subsequent analysis of intact, low concentration, agent genomic nucleic acids and proteins from environmental filters of various compositions.
  • Inhibitors for use in transport “buffers” to allow for the immediate transport and indefinite storage of environmental filters to prevent the degradation of nucleic acid and protein signatures.
  • Development of techniques, methods, stabilizers, preservatives, to allow for the recovery and culture of “live” or “viable” biological materials and organisms, and viruses from environmental collectors.
  • Development of technologies that allow recovery of live bacterial or viral agents from the air such that the sample can be analyzed for specific nucleic acid content (PCR or sequencing) as well as follow on growth of the organism.
  • Novel technologies which allow the inspection of sealed systems (cargo containers, boxes, bottles, etc.) in a non-intrusive way that can be used in normal screening of enclosed containers for biological and/or chemical weapons.

Responses to this RFI will assist DHS in understanding the number and nature of potentially available solutions. Current demonstrated ability to meet all desired capabilities is not necessary. Respondents may choose one or more areas to submit a response.

The effort is overseen by DHS’ Science and Technology (S&T) Directorate Chemical and Biological Defense Division (CBD). Additional details on are available via Solicitation Number: HSHQDC-17-RFI-01. The white paper submission deadline is December 31, 2016.

Tags: BioterrorismBioWatchChemical DetectionHomeland SecurityRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC